These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6482733)

  • 1. Selective urinary excretion of phosphatidyl ethanolamine in patients with chronic glomerular diseases.
    Mimura K; Yukawa S; Maeda T; Kinoshita M; Yamada Y; Saika Y; Miyai T; Nagae M; Mune M; Nomoto H
    Metabolism; 1984 Oct; 33(10):882-90. PubMed ID: 6482733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High density lipoproteinuria in nephrotic syndrome.
    de Mendoza SG; Kashyap ML; Chen CY; Lutmer RF
    Metabolism; 1976 Oct; 25(10):1143-9. PubMed ID: 184367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative and quantitative analysis of urinary lipids in the nephrotic syndrome.
    Klahr S; Tripathy K; Bolanos O
    J Clin Invest; 1967 Sep; 46(9):1475-81. PubMed ID: 6036540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary cholesterol: its association with a macromolecular protein-lipid complex.
    Jüngst D; Weiser H; Siess E; Karl HJ
    J Lipid Res; 1984 Jul; 25(7):655-64. PubMed ID: 6434678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine of patients with nephrotic syndrome contains the plasma type of PAF-acetylhydrolase associated with lipoproteins.
    Balafa OC; Karabina SA; Pappas CA; Elisaf M; Tselepis AD; Siamopoulos KC
    Nephron Physiol; 2004; 97(3):p45-52. PubMed ID: 15292677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary excretion of alpha-1-microglobulin and complement components in patients with chronic glomerulonephritis].
    Niemir Z; Idasiak I; Ostrowski M; Polcyn M; Krzymański M
    Przegl Lek; 1994; 51(8):333-8. PubMed ID: 7532869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of urinary phospholipids in the chronic kidney disease patients.
    Yang WL; Bai Q; Li DD; A TL; Wang S; Zhao RS; Nie HG; Zhang AH; Wang T; Fan MH
    Biomarkers; 2013 Nov; 18(7):601-6. PubMed ID: 24033083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary oval fat body and fat cylinder count in nephrotic syndrome].
    Minetti L; Scatizzi A; Grossi C
    Arch Ital Urol Nefrol; 1969; 42(2):180-98. PubMed ID: 5400334
    [No Abstract]   [Full Text] [Related]  

  • 10. Compartmentalization of phospholipids for lipoprotein assembly on the basis of molecular species and biosynthetic origin.
    Vance JE
    Biochim Biophys Acta; 1988 Nov; 963(1):70-81. PubMed ID: 3140901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characterization of the urinary lipid from humans with nephrotic syndrome.
    Martin RS; Small DM
    J Lab Clin Med; 1984 May; 103(5):798-810. PubMed ID: 6715958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary fibrin-fibrinogen degradation products in nephrotic syndrome.
    Hall CL; Pejhan N; Terry JM; Blainey JD
    Br Med J; 1975 Feb; 1(5955):419-22. PubMed ID: 803853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of apolipoproteins bound to HDL-like particles in rat nephrotic syndrome and their relation to plasma HDL.
    Shafrir E; Levy E; Deckelbaum R
    Nephron; 1990; 56(1):24-9. PubMed ID: 2234246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary kallikrein excretion in glomerulonephritis and nephrotic syndrome.
    Cumming AD; Robson JS
    Nephron; 1985; 39(3):206-10. PubMed ID: 3844632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of newly synthesized phospholipids for assembly into secreted hepatic lipoproteins.
    Vance JE
    Biochim Biophys Acta; 1989 Nov; 1006(1):59-69. PubMed ID: 2508747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
    Joven J; Villabona C; Vilella E; Masana L; Albertí R; Vallés M
    N Engl J Med; 1990 Aug; 323(9):579-84. PubMed ID: 2381443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Components of kallikrein-kinin system in the urine of patients with glomerulonephritis].
    Paskhina TS; Poliantseva LR; Platonova LV; Levina GO
    Vopr Med Khim; 1990; 36(4):62-9. PubMed ID: 2173275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary prostaglandins and thromboxane in patients with chronic glomerulonephritis.
    Niwa T; Maeda K; Shibata M
    Nephron; 1987; 46(3):281-7. PubMed ID: 3627322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.
    Vuong TD; Stroes ES; Willekes-Koolschijn N; Rabelink TJ; Koomans HA; Joles JA
    Kidney Int; 1999 Mar; 55(3):1005-10. PubMed ID: 10027937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Total and fractionized plasma phospholipids in chronic liver diseases].
    Cantoni L; Andreuzzi P; Curri SB; Rocchetti P
    Minerva Med; 1975 Jan; 66(3):101-28. PubMed ID: 1118075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.